Nine Monthly Results Results Snapshot
Figures in Cr
Consolidate Nine Monthly Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Net Sales
345.97
254.52
215.20
182.22
392.14
Other Operating Income
0.00
0.00
0.00
0.00
0.00
Total Operating income
345.97
254.52
215.20
182.22
392.14
Raw Material Cost
161.14
113.13
106.08
82.65
171.24
Purchase of Finished goods
11.32
9.41
0.86
0.03
3.30
(Increase) / Decrease In Stocks
-0.68
-0.83
0.21
-7.28
-6.23
Employee Cost
39.83
31.10
23.57
22.08
14.31
Power Cost
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
-0.02
-0.01
0.00
0.00
0.01
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
Other Expenses
54.90
47.22
38.79
36.10
54.07
Total Expenditure (Excl Depreciation)
266.49
200.02
169.51
133.58
236.70
Operating Profit (PBDIT) excl Other Income
79.48
54.50
45.69
48.64
155.44
Other Income
1.80
1.15
1.25
1.48
1.91
Operating Profit (PBDIT)
81.28
55.65
46.94
50.12
157.35
Interest
8.08
7.38
7.33
4.35
1.89
Exceptional Items
-0.83
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
72.37
48.27
39.61
45.77
155.46
Depreciation
14.54
13.21
14.49
10.53
7.93
Profit Before Tax
57.83
35.06
25.11
35.26
147.53
Tax
15.79
9.74
5.82
8.57
37.72
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
Profit After Tax
42.04
25.32
19.30
26.68
109.80
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
Net Profit
42.04
25.32
19.30
26.68
109.80
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.01
0.03
0.07
0.03
Other related items
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
42.05
25.36
19.35
26.66
109.84
Equity Capital
10.38
10.38
10.38
10.38
10.38
Face Value
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
Diluted Earnings per share
15.42
8.21
7.39
6.82
15.2
Operating Profit Margin (Excl OI)
22.97%
21.41%
21.23%
26.69%
39.64%
Gross Profit Margin
20.92%
18.97%
18.41%
25.12%
39.64%
PAT Margin
12.15%
9.95%
8.97%
14.64%
28.0%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
Nine Monthly Analysis Highlights
Net Sales
YoY Growth in nine months ended Dec 2025 is 35.93% vs 18.27% in Dec 2024
Consolidate Net Profit
YoY Growth in nine months ended Dec 2025 is 65.81% vs 31.06% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in nine months ended Dec 2025 is 45.83% vs 19.28% in Dec 2024
Interest
YoY Growth in nine months ended Dec 2025 is 9.49% vs 0.68% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in nine months ended Dec 2025 has improved from Dec 2024
Compare Nine Monthly Results Of Kwality Pharma With
Figures in Cr
Consolidate Nine Monthly Results
Change(INR)
Change(%)
Net Sales
345.97
665.59
-319.62
-48.02%
Other Operating Income
0.00
0.00
0.00
Total Operating income
345.97
665.59
-319.62
-48.02%
Raw Material Cost
161.14
404.67
-243.53
-60.18%
Purchase of Finished goods
11.32
0.00
11.32
(Increase) / Decrease In Stocks
-0.68
5.52
-6.20
-112.32%
Employee Cost
39.83
110.73
-70.90
-64.03%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
-0.02
-0.01
-0.01
-100.00%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
54.90
65.21
-10.31
-15.81%
Total Expenditure (Excl Depreciation)
266.49
586.12
-319.63
-54.53%
Operating Profit (PBDIT) excl Other Income
79.48
79.47
0.01
0.01%
Other Income
1.80
13.45
-11.65
-86.62%
Operating Profit (PBDIT)
81.28
92.92
-11.64
-12.53%
Interest
8.08
3.35
4.73
141.19%
Exceptional Items
-0.83
0.00
-0.83
Gross Profit (PBDT)
72.37
89.57
-17.20
-19.20%
Depreciation
14.54
22.75
-8.21
-36.09%
Profit Before Tax
57.83
66.82
-8.99
-13.45%
Tax
15.79
16.35
-0.56
-3.43%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
42.04
50.46
-8.42
-16.69%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
42.04
50.46
-8.42
-16.69%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
42.05
50.46
-8.41
-16.67%
Equity Capital
10.38
10.54
-0.16
-1.52%
Face Value
10.00
5.00
0.00
Reserves
0.00
0.00
0.00
Gross Profit Margin
20.92%
13.46%
0.00
7.46%
PAT Margin
12.15%
7.58%
0.00
4.57%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 345.97 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 35.93% vs 18.27% in Dec 2024
Nine Monthly - Consolidate Net Profit
Consolidate Net Profit 42.05 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 65.81% vs 31.06% in Dec 2024
Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 79.48 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 45.83% vs 19.28% in Dec 2024
Nine Monthly - Interest
Interest 8.08 Cr
in Dec 2025Figures in Cr
YoY Growth in nine months ended Dec 2025 is 9.49% vs 0.68% in Dec 2024
Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 22.97%
in Dec 2025Figures in %
YoY Growth in nine months ended Dec 2025 has improved from Dec 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
